Yoshiiku Kawakami

Medicine · Health Sciences

54h-index21.1kcitations225works2.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(83), Hepatitis C virus research(79), Hepatitis B Virus Studies(54), Hepatocellular Carcinoma Treatment and Prognosis(43), Cancer Genomics and Diagnostics(32)

Publications178 total

Prediction of Hepatocellular Carcinoma After Hepatitis C Virus Sustained Virologic Response Using a Random Survival Forest Model
JCO Clinical Cancer Informatics·2024· 2 citedOpen Access
The impact of interferon‐free direct‐acting antivirals on clinical outcome after curative treatment for hepatitis C virus–associated hepatocellular carcinoma: Comparison with interferon‐based therapy
Journal of Medical Virology·2018· 34 cited
Early experience of seven hepatocellular carcinoma cases treated with regorafenib
Clinical Case Reports·2018· 6 citedOpen Access
Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytes
Virology·2018· 29 cited
Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
Oncotarget·2018· 4 citedOpen Access
Comparison of hepatic arterial infusion chemotherapy between 5‐fluorouracil‐based continuous infusion chemotherapy and low‐dose cisplatin monotherapy for advanced hepatocellular carcinoma
Hepatology Research·2018· 15 cited
Advanced liver fibrosis effects on the response to sofosbuvir‐based antiviral therapies for chronic hepatitis C
Journal of Medical Virology·2018· 12 cited
<scp>CTL</scp>‐associated and <scp>NK</scp> cell‐associated immune responses induce different <scp>HBV DNA</scp> reduction patterns in chronic hepatitis B patients
Journal of Viral Hepatitis·2018· 10 cited
Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals
Hepatology International·2018· 51 citedOpen Access
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial
BMC Cancer·2018· 26 citedOpen Access
IDDF2018-ABS-0110 Efficacy and safety of SOFOSBUVIR/VELPATASVIR plus RIBAVIRIN for 12 or 24 weeks in genotype 1 or 2 HCV-INFECTED japanese patients with prior treatment failure to daa-based regimens
2018Open Access
Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
Oncotarget·2018· 73 citedOpen Access
Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real‐world practice
Hepatology Research·2018· 46 cited
Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status
Journal of Gastroenterology and Hepatology·2018· 40 cited
In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors
Genome Research·2018· 187 citedOpen Access
Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring
PLoS ONE·2018· 47 citedOpen Access
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations
Journal of Hepatology·2018· 361 citedOpen Access
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis
Oncology·2018· 48 cited
Primary hepatic follicular lymphoma: A case report
Kanzo·2018· 1 citedOpen Access
HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients
PLoS ONE·2017· 20 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Kazuaki Chayama(47), Hiroshi Aikata(34), Michio Imamura(29), Masataka Tsuge(21), Tomokazu Kawaoka(19), Akira Hiramatsu(18), Shoichi Takahashi(15), Hidenori Ochi(15), Takashi Nakahara(11), Hideyuki Hyogo(11), Nobuhiko Hiraga(11), C. Nelson Hayes(10), Koji Arihiro(9), Hiromitsu Kumada(9), Kei Morio(9), Tomoki Kobayashi(9), Michiaki Kubo(8), Hidewaki Nakagawa(8), Yuko Nagaoki(8), Masahiro Hatooka(8)